Inventor · disambiguated record
Fumie Yamaguchi
Also filed as: YAMAGUCHI FUMIE
1 granted patent·5 pending applications·0 citations·filing 2020–2024
14Inventor score
Files withTAKEDA PHARMACEUTICALS CO6
Top patents by PatentIndex Score
6 records- 0178US11834409B2Heterocyclic NMDA antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Dec 5, 2023·0 cites·22 claims
- 0264US2023002318A1Heterocyclic nmda antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 0363US2024309016A1Macrocyclic heterocycle compounds and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0462US2024217957A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 0550US2023348435A11-((1h-pyrazol-4-yl)methyl)-3-(phenyl)-1,3-dihydro-2h-imidazol-2-one derivatives and related compounds as gpr139 antagonists for the treatment of e.g. depressionTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 0643US2022089525A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fumie Yamaguchi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →